Culture medium for rapidly proliferating neural stem cells
A neural stem cell and cell culture technology, applied in the field of fast-proliferating neural stem cell culture medium, can solve the problems affecting the proliferation rate of neural stem cells, single medium components, etc., and achieve the effects of reducing culture cost, avoiding local differentiation, and improving division speed.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0022] An embodiment of the present invention provides a culture medium for rapidly proliferating neural stem cells, which includes the following composition: DMEM / F12 medium is used as a base material, the content of epidermal growth factor is 20 ng / mL, the content of transferrin is 10 μg / mL, alkali The content of fibroblast growth factor was 20ng / mL, the content of fibronectin was 25ng / mL, the content of type IV collagen was 50ng / mL, and the content of antibiotics was 90U / mL penicillin, 0.13mg / mL Streptomycin and 300ng / mL amphotericin are mixed, the content of bovine serum albumin is 60 μg / mL, the content of non-essential amino acids is 9 μmol / mL and the volume content accounts for 2% of the DMEM / F12 medium for B27 cell culture additive.
[0023] Wherein, the non-essential amino acid is one or a mixture of glutamic acid, tyrosine, proline, glycine, cystine, alanine, aspartic acid or serine.
[0024] A method for rapidly proliferating neural stem cell culture medium, compris...
Embodiment 2
[0027] An embodiment of the present invention provides a culture medium for rapidly proliferating neural stem cells, which includes the following composition: DMEM / F12 medium is used as a base material, the content of epidermal growth factor is 15 ng / mL, the content of transferrin is 15 μg / mL, alkali The content of fibroblast growth factor was 25ng / mL, the content of fibronectin was 15ng / mL, the content of type IV collagen group was 60ng / mL, and the content of antibiotics was 95U / mL penicillin, 0.05mg / mL Streptomycin and 250ng / mL amphotericin are mixed, the content of bovine serum albumin is 40μg / mL, the content of non-essential amino acids is 8μmol / mL and the volume content accounts for 3% of the DMEM / F12 medium B27 cell culture additive.
[0028] Wherein, the non-essential amino acid is one or a mixture of glutamic acid, tyrosine, proline, glycine, cystine, alanine, aspartic acid or serine.
[0029] A method for rapidly proliferating neural stem cell culture medium, compris...
Embodiment 3
[0032] An embodiment of the present invention provides a culture medium for rapidly proliferating neural stem cells, which includes the following composition: DMEM / F12 medium is used as a base material, the content of epidermal growth factor is 25 ng / mL, the content of transferrin is 12 μg / mL, alkali The content of fibroblast growth factor was 15ng / mL, the content of fibronectin was 20ng / mL, the content of type IV collagen group was 70ng / mL, and the content of antibiotics was 110U / mL penicillin, 0.1mg / mL Streptomycin and 200ng / mL amphotericin are mixed, the content of bovine serum albumin is 50 μg / mL, the content of non-essential amino acids is 10 μmol / mL and the volume content accounts for 2% of the DMEM / F12 medium for B27 cell culture additive.
[0033] Wherein, the non-essential amino acid is one or a mixture of glutamic acid, tyrosine, proline, glycine, cystine, alanine, aspartic acid or serine.
[0034] A method for rapidly proliferating neural stem cell culture medium, ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com